Appointed
Aaron Roseth
Chief Operating Officer
XRN ·
Chiron Real Estate Inc.
Aaron Roseth, age 51, was appointed as Chief Operating Officer of the Company and IAM.
Ready 8-Ks
50
Latest filing
August 17, 2026, 4:51 PM ET
Top materiality
0.90
Event mix
earnings ×15 · other_material ×14 · leadership ×8
Sentiment
9 pos · 7 neg · 34 neu
Latest earnings
reported 2025-FY
Executive change
recent →
Recent 8-K filings for XRN
Highest-materiality recent filing
Chiron signs $425M senior housing acquisitions, $100M equity investment, cuts dividend 36%
- Agreed to acquire three senior housing communities in DC metro for ~$425M, expected to close in Q2/Q4 2026.
- Secured $100M convertible preferred equity from Maewyn Capital Partners at 6.00%, initial conversion $43/share.
-
Chiron completes $248.9M acquisition of two Alexandria senior housing communities
The Landing Alexandria acquired for $130M; The Riviera Alexandria for $118.9M, both in Alexandria, VA.
-
Chiron Real Estate Q2 net income $63.3M ($4.78/diluted); acquires $249M SHOP communities
Q2 net income $63.3M ($4.78/diluted) vs prior-year net loss $0.8M; Core FFO $1.04/unit vs $1.14.
-
Chiron Real Estate appoints Matthew Whitlock as CIO; Alfonzo Leon transitions to Strategic Advisor
Matthew Whitlock appointed Chief Investment Officer effective Aug 3, 2026; base salary $400,000, target bonus 100%.
-
Chiron Real Estate appoints new Chief Development Officer and COO; Holley becomes CAO
Robert Zeiller appointed Chief Development Officer and Head of Seniors Housing; Aaron Roseth appointed COO, effective July 16, 2026.
-
Acquired The Riviera and The Landing SHOP communities in June 2026 for $249M total; Riviera 23% occupied, Landing 93% occupied.
-
Chiron Real Estate sells seven rehab hospitals for $217M, retains 15% JV interest
Sold seven inpatient rehabilitation hospitals in PA, AZ, TX, NV, OK for $217M; closed June 29, 2026.
-
Acquired The Landing Alexandria ($130M) and The Riviera Alexandria ($118.9M) on June 1, 2026.
-
Chiron appoints Charles Fitzgerald to board; declares Q2 preferred dividends
Charles Fitzgerald appointed to Board effective May 20, 2026; serves on Compensation and Nominating Committees.
-
Chiron Real Estate enters $100M preferred equity deal with Maewyn XRN LP
Company enters $100M preferred equity purchase agreement with Maewyn XRN LP; initial closing of at least $25M by June 20, 2026.
-
Chiron signs $425M senior housing acquisitions, $100M equity investment, cuts dividend 36%
Agreed to acquire three senior housing communities in DC metro for ~$425M, expected to close in Q2/Q4 2026.
-
Chiron Real Estate files for up to $75M Preferred ATM and updates Common ATM with $288M remaining
Preferred ATM program launched for up to $75M of Series B Preferred Stock; agents get up to 2.0% commission.
-
Chiron Real Estate enters $150M uncommitted senior note facility with NYL Investors
Master Note and Guaranty Agreement with NYL Investors LLC establishes uncommitted facility for up to $150M aggregate principal.
-
Q4 GAAP net loss $7.4M ($0.55/sh) vs. prior year net income $1.4M ($0.10/sh).
-
Director Henry Cole to step down at 2026 Annual Meeting
Henry Cole notified Board he will leave as director effective at 2026 Annual Meeting.
-
Director Ronald Marston to retire at 2026 annual meeting
Ronald Marston notified board on December 3, 2025 of intent to retire as director.
-
Global Medical REIT to issue 2M shares of 8.00% Series B Preferred Stock at $25/share
Offering of 2,000,000 shares (plus 300,000 over-allotment) of 8.00% Series B cumulative redeemable preferred stock at $25.00 per share.
-
Global Medical REIT Q3 2025 net loss of $6.0M vs income $1.8M YoY; occupancy 95.2%
Net loss $6.0M ($0.45/diluted share) vs net income $1.8M ($0.14) in Q3 2024.
-
Global Medical REIT Q3 net loss $6.0M vs income $1.8M; FFO/AFFO up 4%; narrows 2025 AFFO guidance
Net loss $6.0M ($0.45/diluted) vs net income $1.8M ($0.14); includes $6.3M impairment on sold Aurora, IL property.
-
Global Medical REIT amends credit facility, extends maturities to 2029-2031, enters $350M hedges
$400M revolver maturity extended to Oct 2029 with two six-month extension options to Oct 2030.
-
Global Medical REIT completes 1:5 reverse stock split; shares to trade on NYSE Sept 22
Effective Sept 19, 2025, every five shares of common stock converted into one; par value remains $0.001.
-
Net loss narrowed to $0.8M ($0.01/diluted share) from $3.1M loss YoY; FFO $0.20/share, AFFO $0.23/share.
-
GMRE appoints Mark Decker as CEO; Jeffrey Busch becomes non-executive Chairman
Mark O. Decker, Jr. appointed CEO and President effective June 23, 2025; also joins Board.
-
Global Medical REIT cuts quarterly common dividend from $0.21 to $0.15 per share
Board declared Q2 2025 common dividend of $0.15/share, down from $0.21; payable July 9 to holders of record June 20.
-
Global Medical REIT stockholders elect seven directors, ratify auditor, approve say-on-pay
All seven director nominees elected with at least 38M votes for; no dissident candidates.
-
GMRE Q1 net income $2.1M ($0.03/diluted); AFFO $0.22/unit; reaffirms FY2025 AFFO guidance
Net income $2.1M ($0.03/diluted) vs $0.8M ($0.01) prior year; AFFO $0.22/unit vs $0.23.
-
GMRE Q4 AFFO $0.22/unit flat YoY; JV with Heitman; 2025 guidance $0.89-$0.93
Q4 2024 net income $1.4M ($0.02/diluted) vs net loss $0.8M (-$0.01) in Q4 2023; full-year net income $0.8M ($0.01) vs $14.8M ($0.23).
-
CEO Jeff Busch to step down by June 30, 2025; will remain as non-executive chairman
CEO Jeffrey Busch to leave by earlier of successor appointment or June 30, 2025; to continue as non-executive chairman.
-
Global Medical REIT updates investor presentation; YTD acquisitions $80.3M at 8.0% cap rate
YTD 2024: $80.3M in acquisitions (15 properties, 254k SF) at 8.0% WA cap rate.
-
GMRE Q3 net income $1.8M ($0.03/diluted), FFO $0.19/unit, AFFO $0.22/unit
Rental revenue $34.2M, down 3.7% YoY; net income fell from $3.1M to $1.8M.
-
New 15-year triple-net lease with CHRISTUS Health at Beaumont, TX facility for robotic surgery, orthopedics, emergency services.
-
Global Medical REIT Q2 net loss $3.1M; Steward risk; $30.8M acquisition closed
Net loss attributable to common stock of $3.1M ($0.05/diluted) vs income $11.8M ($0.18) Q2 2023; includes $3.4M loss on sale.
-
Global Medical REIT board sets annual say-on-pay vote after stockholder advisory result
Advisory vote: 34,040,745 for every year, 158,991 for two years, 1,098,203 for three years, 566,323 abstained, 13,706,822 broker non-votes.
-
Global Medical REIT posts updated investor presentation; no material new information
Presentation dated June 3, 2024, posted on company website; no earnings or guidance changes.
-
Stockholders approved amendment to 2016 Equity Incentive Plan, increasing reserved shares by 1,500,000.
-
GMRE Q1 net income $0.8M, AFFO $0.23/share; Steward Health Care files Chapter 11
Net income $0.8M ($0.01/diluted share); FFO $14.9M ($0.21/unit); AFFO $16.5M ($0.23/unit).
-
Global Medical REIT transfers ATM program to new registration after losing WKSI status
Filed Prospectus Supplement to move ATM Program from Post-Effective Amendment No.1 to No.2.
-
Global Medical REIT moves ATM program to post-effective amendment after losing WKSI status
Company no longer qualifies as well-known seasoned issuer after filing 2023 Form 10-K.
-
Global Medical REIT posts Q4 net loss of $0.8M; full-year AFFO $0.91/share, leverage down to 43.6%
Q4 net loss attributable to common stockholders of $0.8M ($0.01 diluted loss per share), vs net income $0.4M in Q4 2022.
-
Global Medical REIT registers $300M at-the-market equity program with forward sale option
Agreement with 14 agents and 9 forward sellers to sell up to $300M in common stock via ATM offerings.
-
Global Medical REIT updates investor presentation; portfolio 96.7% occupied, $1.4B gross assets
Portfolio: 185 buildings, 268 tenants, 4.7M sq ft, 96.7% occupancy as of Sept 30, 2023.
-
GMRE Q3 net income $3.1M ($0.05/diluted), FFO $0.22, revenue $35.5M; occupancy 96.7%
Net income attributable to common stockholders $3.1M ($0.05/diluted) vs $8.1M ($0.12) in prior-year Q3.
-
Global Medical REIT Q2 net income $11.8M; core FFO/AFFO down YoY; reduces leverage to 44.5%
Net income $11.8M ($0.18/diluted) vs $2.2M ($0.03) in prior year; includes $12.8M gain on sale.
-
Global Medical REIT updates investor presentation with portfolio data as of March 31, 2023
Portfolio occupancy 97%, weighted average lease term 6.0 years, 188 buildings, 274 tenants.
-
Global Medical REIT posts updated investor presentation; portfolio metrics as of March 31, 2023
Portfolio occupancy 97%, weighted-average lease term 6.0 years, 188 buildings, 274 tenants.
-
All seven nominated directors elected with 33.5M to 35.1M votes in favor; broker non-votes of ~14.5M.
-
Net income $0.7M ($0.01 diluted EPS) vs $2.7M ($0.04) YoY; FFO $15.1M ($0.22/shr) vs $16.0M ($0.23); AFFO $16.0M ($0.23) vs $16.8M ($0.24).
-
Global Medical REIT Q4 net income falls to $0.01 EPS; revenue up 19.6% to $36.3M
Q4 net income $0.4M ($0.01 diluted EPS) vs $3.8M ($0.06) YoY; AFFO flat at $0.24/share.
-
Director Dr. Roscoe Moore to retire at 2023 Annual Meeting, not seeking re-election
Dr. Roscoe Moore, Jr. notified Board of intent to retire as director, effective at 2023 Annual Meeting.
-
Global Medical REIT adopts amended bylaws to comply with federal proxy rules
Board adopted Fourth Amended and Restated Bylaws effective December 7, 2022, to ensure compliance with Rule 14a-19 under the Exchange Act.
-
Global Medical REIT updates investor presentation with 97% occupancy, $149M YTD acquisitions
Portfolio as of Sept 30, 2022: 97% occupied, 6.4-year WALT, 189 buildings, 4.9M sq ft.
Executive changes
Appointed
Robert Zeiller
Chief Development Officer and Head of Seniors Housing
XRN ·
Chiron Real Estate Inc.
Robert “Bobby” Zeiller, age 56, was appointed as Chief Development Officer and Head of Seniors Housing of Chiron Real Estate Inc. (the “Company”) and Inter-American Management LLC (“IAM”), and Aaron Roseth, age 51, was appointed as Chief Operating Officer of the Company and IAM.
Role change
Danica Holley
Chief Administrative Officer
XRN ·
Chiron Real Estate Inc.
Danica Holley transitioned from Chief Operating Officer to Chief Administrative Officer of the Company and IAM, effective July 16, 2026.
Appointed
Charles Fitzgerald
Director
XRN ·
Chiron Real Estate Inc.
On May 20, 2026, the Board of Directors (the “ Board ”) of Chiron Real Estate Inc. (the “ Company ”) approved an increase in the number of directors constituting the Board from six to seven directors and appointed Charles Fitzgerald to serve as a director of the Company, effective as of the same day, to serve until the Company’s 2027 Annual Meeting of Stockholders and until his successor is duly elected and qualified.
Appointed
Mark O. Decker, Jr.
Chief Executive Officer and President
XRN ·
Chiron Real Estate Inc.
Mark O. Decker, Jr, age 49, was appointed Chief Executive Officer and President of the Company, effective as of June 23, 2025.
Role change
Jeffrey M. Busch
non-executive Chairman
XRN ·
Chiron Real Estate Inc.
Mr. Busch was removed from his position as Chief Executive Officer and President of the Company, effective June 23, 2025. Mr. Busch will continue to serve on the board of directors of the Company (the “Board”) as non-executive Chairman.
Appointed
Mark O. Decker, Jr.
Director
XRN ·
Chiron Real Estate Inc.
the Board also increased the size of the Board from seven directors to eight directors and appointed Mr. Decker as a director effective June 23, 2025
Departed
Dr. Roscoe Moore, Jr.
director
XRN ·
Chiron Real Estate Inc.
On January 19, 2023, Dr. Roscoe Moore, Jr. notified the Board of Directors (the “Board”) of Global Medical REIT Inc. (the “Company”) that he intends to retire as a director of the Board, effective as of the Company’s 2023 Annual Meeting of Stockholders (the “Annual Meeting”).
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.90 · Median 0.62 · Most common event earnings